Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.

@article{Tan2014RandomizedCT,
  title={Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion.},
  author={Mei Hong Tan and Ian L. McAllister and Mark E Gillies and Nitin Verma and Gayatri Banerjee and Lynne A Smithies and Wan-ling Wong and Tien Yin Wong},
  journal={American journal of ophthalmology},
  year={2014},
  volume={157 1},
  pages={237-247.e1}
}
PURPOSE To assess the efficacy of intravitreal 0.5 mg ranibizumab for the treatment of center-involving macular edema secondary to branch retinal vein occlusion (BRVO) over 1 year compared with standard-of-care grid laser. DESIGN A prospective randomized controlled clinical trial. METHODS A total of 36 patients with vision loss in 1 eye attributable to macular edema following BRVO were recruited from 5 institutions. Patients were randomized 1:1 to a treatment group that received 6 monthly… CONTINUE READING
16 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…